(Q68428908)

English

Elimination of cycling CD4+ suppressor T cells with an anti-mitotic drug releases non-cycling CD8+ T cells to cause regression of an advanced lymphoma

scientific article published on 01 September 1990

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2145216%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

Elimination of cycling CD4+ suppressor T cells with an anti-mitotic drug releases non-cycling CD8+ T cells to cause regression of an advanced lymphoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2145216%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

author name string

R J North

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2145216%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

M Awwad

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2145216%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

publication date

1 September 1990

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2145216%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2145216%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

71

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2145216%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2145216%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

90-95

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2145216%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

An in vitro assay for growth-inhibiting activity of vinblastine

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145216

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

T-cell-mediated suppression of anti-tumor immunity. An explanation for progressive growth of an immunogenic tumor

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145216

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Generation and decay of the immune response to a progressive fibrosarcoma. I. Ly-1+2- suppressor T cells down-regulate the generation of Ly-1-2+ effector T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145216

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adoptive immunization against an established tumor with cytolytic versus memory T cells. Immediate versus delayed onset of regression.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145216

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Down-regulation of the antitumor immune response.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145216

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiation-induced, immunologically mediated regression of an established tumor as an example of successful therapeutic immunomanipulation. Preferential elimination of suppressor T cells allows sustained production of effector T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145216

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sublethal, whole-body ionizing irradiation can be tumor promotive or tumor destructive depending on the stage of development of underlying antitumor immunity

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145216

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145216

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin 4 promotes the growth of tumor-infiltrating lymphocytes cytotoxic for human autologous melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145216

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunologically mediated regression of a murine lymphoma after treatment with anti-L3T4 antibody. A consequence of removing L3T4+ suppressor T cells from a host generating predominantly Lyt-2+ T cell-mediated immunity

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145216

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclophosphamide-induced immunologically mediated regression of a cyclophosphamide-resistant murine tumor: a consequence of eliminating precursor L3T4+ suppressor T-cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145216

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Elimination of CD4+ suppressor T cells from susceptible BALB/c mice releases CD8+ T lymphocytes to mediate protective immunity against Leishmania

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145216

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clonal analysis of cytotoxic and regulatory T cell responses against human melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145216

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. II. Sequential changes in alloreactivity of T cell subsets

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145216

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanisms maintaining antibody-induced enhancement of allografts. II. Mediation of specific suppression by short lived CD4+ T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145216

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Importance of Lyt 2+ T-cells in the curative effectiveness of a low dose of melphalan for mice bearing a large MOPC-315 tumor

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145216

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A CD4 cell is capable of transferring suppression of collagen-induced arthritis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2145216

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2145216%20AND%20SRC:MED&resulttype=core&format=json

24 September 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q68428908&oldid=1811705778"